Necrostatin-1 enhances the resolution of inflammation by specifically inducing neutrophil apoptosis

Oncotarget

Volumn 7, Issue 15, 2016, Pages 19367-19381

  Jie, Hongyu ^a,b   He, Yi ^a,b   Huang, Xuechan ^a,b   Zhou, Qingyou ^a,b   Han, Yanping ^a,b,c   Li, Xing ^a,b   Bai, Yongkun ^a,b   Sun, Erwei ^a,b  

^a THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

^b Academy of Orthopedics   (China)

^c SOUTH CHINA NORMAL UNIVERSITY   (China)

Author keywords

Apoptosis; Inflammation; Necrostatin 1; Neutrophil

Indexed keywords

ANTIINFLAMMATORY AGENT; CASPASE 3; CELL PROTEIN; CYTOCHROME C; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NECROSTATIN 1; PROTEIN BAX; PROTEIN MCL 1; PROTEIN RIP1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CYTOKINE; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; NECROSTATIN-1; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; INHIBITION KINETICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NECROPTOSIS; NEUTROPHIL; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; PYROPTOSIS; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; LUNG; MALE; METABOLISM; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYTOKINES; HUMANS; IMIDAZOLES; INDOLES; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG; MALE; MICE, INBRED C57BL; NEUTROPHILS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES;

EID: 84964712028     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8346     Document Type: Article

References (60)

1. Degterev A, Maki JL and Yuan J. Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase. Cell Death Differ. 2013; 20:366.
2. Segal AW. How neutrophils kill microbes. Annual review of immunology. 2005; 23:197-223.
3. Amulic B, Cazalet C, Hayes GL, Metzler KD and Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012; 30:459-489.
4. Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM and Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol. 2010; 31:318-324.
5. Bratton DL and Henson PM. Neutrophil clearance: when the party is over, clean-up begins. Trends Immunol. 2011; 32:350-357.
6. Dzhagalov I, St John A and He YW. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. Blood. 2007; 109(4):1620-1626.
7. Geering B and Simon HU. Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ. 2011; 18:1457-1469.
8. Maianski NA, Geissler J, Srinivasula SM, Alnemri ES, Roos D and Kuijpers TW. Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis. Cell Death Differ. 2004; 11:143-153.
9. Kennedy AD and DeLeo FR. Neutrophil apoptosis and the resolution of infection. Immunol Res. 2009; 43:25-61.
10. Garlichs CD, Eskafi S, Cicha I, Schmeisser A, Walzog B, Raaz D, Stumpf C, Yilmaz A, Bremer J, Ludwig J and Daniel WG. Delay of neutrophil apoptosis in acute coronary syndromes. J Leukoc Biol. 2004; 75:828-835.
11. Matute-Bello G, Liles WC, Radella F, 2nd, Steinberg KP, Ruzinski JT, Jonas M, Chi EY, Hudson LD and Martin TR. Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997; 156:1969-1977.
12. Cascao R, Rosario HS, Souto-Carneiro MM and Fonseca JE. Neutrophils in rheumatoid arthritis: More than simple final effectors. Autoimmun Rev. 2010; 9:531-535.
13. Keel M, Ungethum U, Steckholzer U, Niederer E, Hartung T, Trentz O and Ertel W. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood. 1997; 90:3356-3363.
14. Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, Cuny GD, Mitchison TJ, Moskowitz MA and Yuan J. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol. 2005; 1:112-119.
15. Vandenabeele P, Grootjans S, Callewaert N and Takahashi N. Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models. Cell Death Differ. 2013; 20:185-187.
16. Zhang A, Mao X, Li L, Tong Y, Huang Y, Lan Y and Jiang H. Necrostatin-1 inhibits Hmgb1-IL-23/IL-17 pathway and attenuates cardiac ischemia reperfusion injury. Transpl Int. 2014; 27:1077-1085.
17. Silke J, Rickard JA and Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat Immunol. 2015; 16:689-697.
18. Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, Goossens V, Roelandt R, Van Hauwermeiren F, Libert C, Declercq W, Callewaert N, Prendergast GC, et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 2012; 3:e437.
19. Jouan-Lanhouet S, Arshad MI, Piquet-Pellorce C, Martin-Chouly C, Le Moigne-Muller G, Van Herreweghe F, Takahashi N, Sergent O, Lagadic-Gossmann D, Vandenabeele P, Samson M and Dimanche-Boitrel MT. TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ. 2012; 19:2003-2014.
20. Obitsu S, Sakata K, Teshima R and Kondo K. Eleostearic acid induces RIP1-mediated atypical apoptosis in a kinaseindependent manner via ERK phosphorylation, ROS generation and mitochondrial dysfunction. Cell Death Dis. 2013; 4:e674.
21. Rossi AG, Sawatzky DA, Walker A, Ward C, Sheldrake TA, Riley NA, Caldicott A, Martinez-Losa M, Walker TR, Duffin R, Gray M, Crescenzi E, Martin MC, et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med. 2006; 12:1056-1064.
22. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M and Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995; 376:37-43.
23. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 1995; 81:801-809.
24. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G and Alnemri ES. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci U S A. 1996; 93:7464-7469.
25. Ofengeim D and Yuan J. Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death. Nat Rev Mol Cell Biol. 2013; 14:727-736.
26. Reutershan J, Basit A, Galkina EV and Ley K. Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2005; 289:L807-815.
27. Gabelloni ML, Trevani AS, Sabatte J and Geffner J. Mechanisms regulating neutrophil survival and cell death. Semin Immunopathol. 2013; 35:423-437.
28. Sun E. Cell death recognition model for the immune system. Med Hypotheses. 2008; 70:585-596.
29. Sun EW and Shi YF. Apoptosis: the quiet death silences the immune system. Pharmacol Ther. 2001; 92:135-145.
30. Ren Y, Xie Y, Jiang G, Fan J, Yeung J, Li W, Tam PK and Savill J. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J Immunol. 2008; 180:4978-4985.
31. Sun E, Gao Y, Chen J, Roberts AI, Wang X, Chen Z and Shi Y. Allograft tolerance induced by donor apoptotic lymphocytes requires phagocytosis in the recipient. Cell Death Differ. 2004; 11:1258-1264.
32. Linkermann A and Green DR. Necroptosis. N Engl J Med. 2014; 370:455-465.
33. Smith CC and Yellon DM. Necroptosis, necrostatins and tissue injury. J Cell Mol Med. 2011; 15:1797-1806.
34. Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ and Yuan J. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 2008; 135:1311-1323.
35. Han W, Xie J, Li L, Liu Z and Hu X. Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis. Apoptosis. 2009; 14:674-686.
36. Leuenroth SJ, Grutkoski PS, Ayala A and Simms HH. The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis. J Leukoc Biol. 2000; 68:158-166.
37. Kato T, Kutsuna H, Oshitani N and Kitagawa S. Cyclic AMP delays neutrophil apoptosis via stabilization of Mcl-1. FEBS Lett. 2006; 580:4582-4586.
38. Lavastre V, Pelletier M, Saller R, Hostanska K and Girard D. Mechanisms involved in spontaneous and Viscum album agglutinin-I-induced human neutrophil apoptosis: Viscum album agglutinin-I accelerates the loss of antiapoptotic Mcl-1 expression and the degradation of cytoskeletal paxillin and vimentin proteins via caspases. J Immunol. 2002; 168:1419-1427.
39. Pelletier M, Ratthe C and Girard D. Mechanisms involved in interleukin-15-induced suppression of human neutrophil apoptosis: role of the anti-apoptotic Mcl-1 protein and several kinases including Janus kinase-2, p38 mitogenactivated protein kinase and extracellular signal-regulated kinases-1/2. FEBS Lett. 2002; 532:164-170.
40. Derouet M, Thomas L, Cross A, Moots RJ and Edwards SW. Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem. 2004; 279:26915-26921.
41. Francois S, El Benna J, Dang PM, Pedruzzi E, Gougerot-Pocidalo MA and Elbim C. Inhibition of neutrophil apoptosis by TLR agonists in whole blood: involvement of the phosphoinositide 3-kinase/Akt and NF-kappaB signaling pathways, leading to increased levels of Mcl-1, A1, and phosphorylated Bad. J Immunol. 2005; 174:3633-3642.
42. Derouet M, Thomas L, Moulding DA, Akgul C, Cross A, Moots RJ and Edwards SW. Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. J Immunol. 2006; 176(2):957-965.
43. Steimer DA, Boyd K, Takeuchi O, Fisher JK, Zambetti GP and Opferman JT. Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function. Blood. 2009; 113:2805-2815.
44. Altznauer F, Conus S, Cavalli A, Folkers G and Simon HU. Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem. 2004; 279:5947-5957.
45. Sawatzky DA, Willoughby DA, Colville-Nash PR and Rossi AG. The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo. Am J Pathol. 2006; 168:33-41.
46. Murphy BM, O'Neill AJ, Adrain C, Watson RW and Martin SJ. The apoptosome pathway to caspase activation in primary human neutrophils exhibits dramatically reduced requirements for cytochrome C. J Exp Med. 2003; 197:625-632.
47. Abraham E. Neutrophils and acute lung injury. Crit Care Med. 2003; 31:S195-199.
48. Liu G, Park YJ, Tsuruta Y, Lorne E and Abraham E. p53 Attenuates lipopolysaccharide-induced NF-kappaB activation and acute lung injury. J Immunol. 2009; 182:5063-5071.
49. Degterev A, Hitomi J, Germscheid M, Ch'en IL, Korkina O, Teng X, Abbott D, Cuny GD, Yuan C, Wagner G, Hedrick SM, Gerber SA, Lugovskoy A, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat Chem Biol. 2008; 4:313-321.
50. Duilio C, Ambrosio G, Kuppusamy P, DiPaula A, Becker LC and Zweier JL. Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol. 2001; 280:H2649-2657.
51. Chen YX, Sato M, Kawachi K and Abe Y. Neutrophilmediated liver injury during hepatic ischemia-reperfusion in rats. Hepatobiliary Pancreat Dis Int. 2006; 5:436-442.
52. Okajima K, Harada N, Uchiba M and Mori M. Neutrophil elastase contributes to the development of ischemiareperfusion-induced liver injury by decreasing endothelial production of prostacyclin in rats. Am J Physiol Gastrointest Liver Physiol. 2004; 287:G1116-1123.
53. Taneja R, Parodo J, Jia SH, Kapus A, Rotstein OD and Marshall JC. Delayed neutrophil apoptosis in sepsis is associated with maintenance of mitochondrial transmembrane potential and reduced caspase-9 activity. Crit Care Med. 2004; 32:1460-1469.
54. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD and Marshall JC. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest. 2004; 113:1318-1327.
55. Wang X, Li Y, Liu S, Yu X, Li L, Shi C, He W, Li J, Xu L, Hu Z, Yu L, Yang Z, Chen Q, et al. Direct activation of RIP3/MLKL-dependent necrosis by herpes simplex virus 1 (HSV-1) protein ICP6 triggers host antiviral defense. Proc Natl Acad Sci U S A. 2014; 111:15438-15443.
56. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, Toy P, Werb Z and Looney MR. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. 2012; 122:2661-2671.
57. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM and Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest. 1989; 83:865-875.
58. Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C and Rossi AG. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem. 1999; 274:4309-4318.
59. Hiroshima Y, Hsu K, Tedla N, Chung YM, Chow S, Herbert C and Geczy CL. S100A8 induces IL-10 and protects against acute lung injury. J Immunol. 2014; 192:2800-2811.
60. Borregaard N. Neutrophils, from marrow to microbes. Immunity. 2010; 33:657-670.